Gitnux/Report 2026

Cosmetic Surgery Industry Statistics

US demand is still climbing, with 2,052,792 cosmetic procedures performed in 2023, and non surgical treatments accounting for 83% of all procedures. See how tastes are shifting toward injectables and skin resurfacing, while safety warnings from the FDA and CDC spotlight why choosing a regulated provider matters as much as chasing the most requested results.
270Statistics
62Sources
12Sections
1Visuals
47mRead
November 11, 2026Updated
Cosmetic Surgery Industry Statistics
Lars EriksenWritten by Lars Eriksen·Edited by Diana Reeves·Fact-checked by Rebecca Hargrove
Published ·Updated
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 31 days

01 Industry overview

The cosmetic surgery industry at a glance

The cosmetic surgery industry is expanding globally: plastic surgeons performed 17.4 million surgical procedures in 2024, while the broader cosmetic surgery and procedure market reached an estimated $72.8 billion in 2025.

$72.8B[52]
Global market size, 2025
17.4M[16]
Global surgical procedures, 2024
1.59M[53]
U.S. cosmetic surgeries, 2024
349,728[53]
U.S. liposuction procedures, 2024
Market size
The global cosmetic surgery and procedure market was valued at $72.8 billion in 2025. Grand View Research estimates that the market will reach $80.0 billion in 2026.[52]
Forecast & CAGR
The global cosmetic surgery and procedure market is projected to reach $161.3 billion by 2033, representing a 10.5% CAGR from 2026 to 2033. A separate aesthetic-surgery-only estimate places the 2026–2033 CAGR at 12.0%.[52]
Market share & regions
North America was identified as the largest regional market in Grand View Research’s 2025 assessment. Globally, ISAPS recorded 17,415,678 surgical procedures in 2024, with 7,497,709 involving the face and head, 3,907,567 involving the breasts, and 6,010,401 involving the body and extremities.[52][16]
Segmentation
The market is commonly segmented by procedure type into breast, face and head, and body and extremities procedures, and by provider setting into cosmetic surgery clinics and hospitals. In the United States in 2024, the leading surgical procedures were liposuction with 349,728 cases, breast augmentation with 306,196, and abdominoplasty with 171,064.[52][53]
Key players & concentration
The industry is fragmented across independent surgeons, specialist clinics, hospitals, medical-spa groups, and device and injectable manufacturers; the available industry sources do not provide a reliable global concentration ratio. In the United States, ASPS statistics cover procedures performed by ASPS member surgeons only, so they should not be interpreted as a complete national market census.[53][16]
Pricing
The average U.S. surgeon fee for breast augmentation with implants was $4,875 in 2023, while the average fee for breast augmentation using fat grafting was $5,719. These are surgeon fees rather than total procedure costs, which can also include anesthesia, facility, implants, and other expenses.[53]
Trends, drivers & challenges
Demand remained resilient in the United States in 2024: cosmetic surgical procedures increased 1% year over year and minimally invasive procedures increased 1.5% among ASPS member surgeons. Key challenges include patient-safety risks, uneven practitioner standards, procedure affordability, and the need for stronger informed-consent and post-procedure monitoring.[53][54]
Consumer behavior & competition
Minimally invasive treatments continue to compete with surgery: ISAPS recorded 20.5 million non-surgical procedures globally in 2024, compared with 17.4 million surgical procedures. Among ASPS member surgeons’ U.S. patients using GLP-1 medicines, 20% had already undergone plastic surgery, 39% were considering surgery, and 41% were considering a non-surgical procedure.[16][53]
M&A
Consolidation is occurring at the clinic-platform level: DermDox Group acquired Modern Aesthetics Plastic Surgery in 2025, adding a three-location Pennsylvania aesthetic medicine and plastic surgery practice to its dermatology platform. The available transaction report did not disclose the purchase price.[55]
Regulation
In the United States, the FDA requires breast-implant manufacturers to provide boxed warnings, patient decision checklists, and implant-specific patient information. FDA safety communications also address risks including breast implant-associated anaplastic large cell lymphoma and implant rupture or removal.[54]
Latest news
The latest major global industry dataset available is ISAPS’s 2024 survey, released on June 19, 2025. It reported more than 17.4 million surgical and 20.5 million non-surgical aesthetic procedures performed worldwide by plastic surgeons, while ISAPS opened data collection for its 2025 survey in 2026.[16]

02 Ranking

Top 10 Companies in the Cosmetic Surgery Industry

The leading companies in the cosmetic surgery industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 11, 2026 · Next review December 11, 2026

Verdict

AbbVie leads Gitnux's 2026 cosmetic surgery ranking with an Overall score of 9.6, with Allergan Aesthetics generating $4.86 billion in global 2025 aesthetics revenue. Galderma is the runner-up at 9.3, backed by $5.207 billion 2025 net sales and 11.5% injectable-aesthetics growth.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in aesthetic injectables

    AbbVie

    US

    Ranked #1 · 9.6 · Aesthetic injectables

    Why we picked it: Its Allergan Aesthetics portfolio spans injectables plus implants and devices, tied to $4.86B revenue.

  2. Leader in breast implant devices

    Establishment Labs

    CR

    Ranked #3 · 8.8 · Breast implant devices

    Why we picked it: Motiva device scale is supported by more than five million devices in the market by 2026.

  3. Leader in energy-based aesthetic devices

    Candela

    US

    Ranked #5 · 8.5 · Energy-based aesthetic devices

    Why we picked it: Its energy-based systems cover laser, IPL and RF microneedling used for aesthetic procedures.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the cosmetic surgery industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

AbbVie

Aesthetic injectables · US

9.6
2

Galderma

Aesthetic injectables · CH

9.3
3

Establishment Labs

Breast implant devices · CR

8.8
4

Revance

Aesthetic injectables · US

8.7
5

Candela

Energy-based aesthetic devices · US

8.5
6

Bausch Health

Solta Medical energy-based aesthetic devices · CA

8.2
7

GC Aesthetics

Breast implants and reconstructive surgery devices · IE

8.2
8

POLYTECH Health & Aesthetics

Breast, gluteal and body-contouring implants · DE

8.1
9

Evolus

Aesthetic injectables and dermal fillers · US

7.8
10

InMode

Minimally invasive energy-based aesthetic devices · IL

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 11, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Lars Eriksen. (2026, February 13). Top 10 companies in the cosmetic surgery industry. In Cosmetic Surgery Industry Statistics. Gitnux. https://gitnux.org/cosmetic-surgery-industry-statistics/#top-companies

report visual · Comparison

Revenue of the largest cosmetic surgery companies

AbbVie leads with $61.2B in annual revenue (group level, converted to USD).

AbbVie$61.2B
Bausch Health$10.3B
Galderma$5.2B
InMode$371M
Evolus$297M
source-verifiedabbvie.com · ir.bauschhealth.com · investors.galderma.com · prnewswire.com · investors.evolus.com2025

04 Statistics

Technology & Innovation

AI adoption and concern coexist: 53.2% of IMCAS 2024 respondents said they were using AI, while 48.9% expressed reservations about AI data privacy and security.

AI in the cosmetic surgery industry

  • 53.2% of IMCAS 2024 respondents said they were currently using AI technologies in cosmetic medicine.[1]
  • 48.9% of IMCAS 2024 respondents expressed reservations about AI data privacy and security in cosmetic medicine.[1]
  • 85.1% of IMCAS 2024 respondents recognized potential AI benefits for diagnosis in cosmetic medicine.[1]
  • 15% of British cosmetic-surgery surgeons reported seeing patients bring AI-generated images of themselves to consultations in 2026, according to a member survey.[2]
  • 70% of physicians in a 2023 32-country cosmetic-medicine survey believed AI could enhance patient outcomes and healthcare quality.[1]
  • 74.5% of IMCAS 2024 respondents recognized potential AI benefits for treatment planning in cosmetic medicine.[1]

Digital Transformation in the healthcare services sector (sector benchmark)

  • Among healthcare respondents to KPMG’s global technology survey, 49% were adopting DevSecOps approaches to adapt digital-transformation strategies.[3]
  • About 90% of surveyed global healthcare C-suite executives expected digital technology use to accelerate in 2025, including 50% anticipating a significant impact.[4]
  • About 70% of surveyed healthcare executives said investing in technology platforms for digital tools and services would be important or very important in 2025.[4]
  • Across U.S. non-federal acute care hospitals, 71% used predictive AI integrated into electronic health records in 2024.[5]
  • Across surveyed healthcare practitioners, 60% believed their organizations’ digital experiences met or exceeded customer needs in 2025.[6]

Technology Adoption in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 81% enabled patient access through applications using application-programming-interface specifications in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 99% enabled patients to view health information electronically in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 84% enabled patients to transmit health information to a third party electronically in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 92% enabled patients to securely message providers in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 96% enabled patients to download health information electronically in 2024.[5]
  • Across U.S. non-federal acute care hospitals, 70% enabled patient access through applications using HL7 FHIR specifications in 2024.[5]

Cloud Computing in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare organizations globally, 8% reported minimal cloud adoption without formal strategy or governance at the end of 2025.[7]
  • Across surveyed healthcare organizations globally, 18% had started adopting cloud services but lacked a comprehensive cloud strategy at the end of 2025.[7]
  • Across surveyed healthcare organizations globally, 27% reported that cloud operations were well managed and integrated into overall IT strategy at the end of 2025.[7]
  • Across surveyed healthcare organizations globally, 31% had a formal cloud strategy and governance framework that was not yet integrated into IT strategy at the end of 2025.[7]
  • Across surveyed healthcare organizations globally, 15% reported that cloud adoption was fully integrated into business strategy at the end of 2025.[7]

Big Data in the healthcare services sector (sector benchmark)

  • Across Brazilian healthcare facilities conducting Big Data analytics, 72% used data from smart devices or sensors in 2024.[8]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 77% used in-house staff rather than external providers in 2024.[8]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 38% used geolocation data from mobile phones, wireless connections, or GPS in 2024.[8]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 48% used social-media data in 2024.[8]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 65% used patient demographics, forms, or medical-record data in 2024.[8]

IoT in the healthcare services sector (sector benchmark)

  • Across Brazilian healthcare facilities with internet access, 4% used IoT in 2024.[9]
  • Among Brazilian private healthcare facilities with internet access, 6% used IoT in 2024.[9]
  • Among Brazilian inpatient healthcare facilities with more than 50 beds and internet access, 19% used IoT in 2024.[9]

05 Statistics

Data & Analytics

Model performance varies by dataset source: the mean accuracy advantage of institutional over public datasets was 7.2 percentage points.

Business intelligence in the cosmetic surgery industry

  • 61% was the mean accuracy of ChatGPT-4o for general facial analysis in a comparative plastic-surgery evaluation.[10]
  • 60% was the mean accuracy of Gemini 1.5 Pro for general facial analysis in a comparative plastic-surgery evaluation.[10]
  • 89.5% was the pooled accuracy for AI models using institutional plastic-surgery datasets in a systematic review.[11]
  • 7.2 percentage points was the mean accuracy advantage of institutional over public datasets in a plastic-surgery AI review.[11]
  • 7,160 photographs from 1,259 patients formed a dataset for automated aesthetic-outcome assessment in facial plastic surgery.[12]
  • 88% was the pooled diagnostic accuracy of artificial-intelligence models across 23 plastic-surgery studies in a systematic review.[10]

Data analytics in the cosmetic surgery industry

  • 0.61 was the mean general-facial-analysis accuracy score for ChatGPT-4o in a multimodal-model plastic-surgery comparison.[10]
  • 55% of patients in that study received classic abdominoplasty recommendations from ChatGPT-4.[13]
  • 10% of patients in that study were advised by ChatGPT-4 not to undergo a procedure.[13]
  • 20% of patients in that study received liposculpture recommendations from ChatGPT-4.[13]
  • 90% of patients in a 20-person study received at least one surgical recommendation from ChatGPT-4 after standardized aesthetic photographs were submitted.[13]
  • 0.52 was the mean general-facial-analysis accuracy score for Claude 3.5 Sonnet in a multimodal-model plastic-surgery comparison.[10]

Data Quality in the healthcare services sector (sector benchmark)

  • 75% of U.S. healthcare organizations represented in the survey predominantly used clinical registry data for quality and process improvement in 2024.[14]
  • 50% of U.S. healthcare clinical data abstractors reported that data inaccuracies hamper clinical registry efforts in 2024.[14]
  • 40% of U.S. healthcare clinical data abstractors reported that incomplete data hampers clinical registry efforts in 2024.[14]
  • 40% of U.S. healthcare clinical data abstractors reported that manual data entry hampers clinical registry efforts in 2024.[14]
  • 8% of U.S. healthcare organizations rated their provider data as excellent in 2022.[15]

Data Governance in the healthcare services sector (sector benchmark)

  • 10% of healthcare organizations managed data governance exclusively within IT in 2025.[15]
  • 66% of healthcare organizations reported multidisciplinary representation in governance, including patient or consumer representatives, in 2025.[15]
  • 38% of healthcare organizations had formal data and information quality-management statements in 2025.[15]
  • 39% of healthcare organizations reported having a formally chartered data-governance function in 2025.[15]
  • 72% of healthcare organizations operated governance using approved policy and standards frameworks in 2025.[15]
  • 77% of healthcare organizations reported that their governance functions met at least quarterly in 2025.[15]

KPIs in the cosmetic surgery industry

  • 13.4% was the year-over-year increase in worldwide eyelid-surgery procedures from 2023 to 2024.[16]
  • 38.9% was the year-over-year increase in worldwide non-surgical skin-tightening procedures from 2023 to 2024.[16]
  • 17.5% was the year-over-year decrease in worldwide breast-augmentation procedures from 2023 to 2024.[16]
  • 17.4% was the year-over-year decrease in worldwide botulinum-toxin procedures from 2023 to 2024.[16]
  • 9.8% was the year-over-year decrease in worldwide rhinoplasty procedures from 2023 to 2024.[16]
  • 12.6% was the year-over-year decrease in worldwide liposuction procedures from 2023 to 2024.[16]

06 Statistics

Strategy & Growth

Procedure demand shows directional splits by category and geography; Galderma’s 2024 net sales rose to $4.410 billion.

Growth in the cosmetic surgery industry

  • Aesthetic medical-equipment revenue at the reporting company increased to approximately RMB57.2 million in 2024 from RMB14.5 million in 2023.[17]
  • Galderma reported $4.410 billion in 2024 net sales, up 9.3% year over year at constant currency.[18]
  • Worldwide aesthetic procedures increased 3.4% in 2023 to 34.9 million surgical and nonsurgical procedures performed by plastic surgeons.[13]
  • Galderma’s injectable-aesthetics net sales reached $2.299 billion in 2024, up 9.6% year over year at constant currency.[18]
  • AbbVie’s Botox Cosmetic net revenue increased 3% in 2024.[19]

Differentiation in the cosmetic surgery industry

  • Non-surgical skin tightening reached 1,239,306 worldwide procedures in 2024, up 38.9% from the prior reported period.[16]
  • Eyelid surgery accounted for 2,115,360 worldwide surgical procedures in 2024, differentiating it as the leading surgical aesthetic treatment by volume.[16]
  • Neck-lift surgery reached 477,624 worldwide procedures in 2024.[16]
  • Chemical peels reached 820,225 worldwide procedures in 2024, up 33.3% from the prior reported period.[16]
  • Facial-bone-contouring surgery reached 237,188 worldwide procedures in 2024, up 44.1% from the prior reported period.[16]

Mergers and acquisitions in the cosmetic surgery industry

  • Beverly JCG agreed to acquire BK Aesthetics Clinic in Singapore in April 2024 through a share exchange valued at S$0.015 per share.[20]
  • Olympus Cosmetic Group completed its acquisition of Artisan Plastic Surgery and Artisan Beauté in May 2024.[21]
  • SBC Medical Group agreed to acquire Singapore-based Aesthetic Healthcare Holdings in an all-cash transaction scheduled to close on November 13, 2024.[22]
  • Crown Aesthetics acquired selected assets and technology from Healeon in the aesthetics platelet-rich-plasma sector in July 2024.[23]

Strategic partnerships in the cosmetic surgery industry

  • Galderma’s NEXT trend report was developed in partnership with nearly 40 global experts in 2024.[18]
  • Galderma’s injectable-aesthetics portfolio was supported by the Galderma Aesthetic Injector Network, which expanded international practitioner education and training in 2024.[18]
  • Galderma reported collaboration with academic and industrial research partners across the world through its dermatology partnership program in 2024.[18]

07 Statistics

People & Workforce

Workforce strain appears alongside partial staffing governance gaps; only 8.6% of surveyed U.S. academic plastic-surgery programs had a formal faculty-retention committee in 2025.

Hiring in the cosmetic surgery industry

  • Assistant professors accounted for 82.4% of faculty additions over the preceding year at surveyed U.S. academic plastic-surgery programs.[10]
  • Assistant professors accounted for 83.7% of faculty additions over the preceding five years at surveyed U.S. academic plastic-surgery programs.[10]
  • U.S. academic plastic-surgery programs reported adding an average of 6.5 faculty members over the preceding ten years in a 2025 survey.[10]
  • U.S. academic plastic-surgery programs reported adding an average of 4.3 faculty members over the preceding five years in a 2025 survey.[10]
  • Assistant professors accounted for 84.6% of faculty additions over the preceding ten years at surveyed U.S. academic plastic-surgery programs.[10]

Employee retention in the cosmetic surgery industry

  • 45% of international plastic-surgery trainees responding to a 2021–2022 survey reported burnout.[13]
  • Faculty retention was 95.8% over one year, 70.9% over five years and 61.1% over ten years in surveyed U.S. academic plastic-surgery programs.[10]
  • Only 8.6% of surveyed U.S. academic plastic-surgery programs had a formal faculty-retention committee in 2025.[10]
  • Inadequate compensation was cited by 34.3% of surveyed U.S. academic plastic-surgery programs as a reason for faculty departures.[10]
  • Faculty turnover was 4.2% over one year, 29.1% over five years and 38.9% over ten years in surveyed U.S. academic plastic-surgery programs.[10]

Remote Work in the healthcare services sector (sector benchmark)

  • Across U.S. health care and social assistance, 18% of full-time employees worked fully from home during December 2024–March 2025.[24]
  • Across U.S. medical groups, 52% reported that 1%–25% of their workforce worked remotely at least 50% of the time.[25]
  • Across U.S. medical groups, 18% of leaders expected their organization’s share of remote or hybrid jobs to decrease during 2024.[25]
  • Across U.S. medical groups, 22% of leaders expected their organization’s share of remote or hybrid jobs to increase during 2024.[25]

Hybrid Work in the healthcare services sector (sector benchmark)

  • Across U.S. healthcare support roles, 14% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[25]
  • About 12% of nonclinical healthcare administrative and customer-support jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[25]
  • Across U.S. healthcare practitioners and technical roles, 16% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[25]
  • Across U.S. health care and social assistance, 24% of full-time employees were in hybrid arrangements during December 2024–March 2025.[24]
  • About 6% of U.S. healthcare jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[25]

Upskilling in the cosmetic surgery industry

  • 33.3% of Canadian plastic-surgery residents used large language models to explain procedures in a 2025 national survey.[13]
  • 70.2% of IMCAS 2024 cosmetic-medicine respondents said they needed further AI-training resources.[1]
  • 94.4% of Canadian plastic-surgery residents surveyed in 2025 reported receiving no education or training on large language models.[13]
  • 50.1% of Canadian plastic-surgery residents surveyed in 2025 reported using large language models at least once per week.[13]
  • 63.8% of IMCAS 2024 respondents reported receiving instruction on AI technologies in cosmetic medicine.[1]

Employee Engagement in the healthcare services sector (sector benchmark)

  • U.S. registered nurses with low teamwork scores were 1.53 times more likely to leave their healthcare organization in 2024.[26]
  • Across 2.3 million U.S. healthcare workers, employee engagement declined by 0.02 points in 2024.[26]
  • Across U.S. healthcare organizations, employee turnover fell from 20% to 18% in 2024.[26]
  • Across NHS staff, the national staff-engagement theme score was 6.64 in the second quarter of 2024/25.[27]
  • Among U.S. healthcare advanced practice providers, 52% felt heard in 2024.[26]

DEI in the cosmetic surgery industry

  • Underrepresented minorities accounted for fewer than 10% of applicants to integrated plastic-surgery residencies in the evidence summarized by a 2024 systematic review.[13]

08 Statistics

Customer & Sales

Operator economics show churn and rebooking metrics tied to acquisition channels; the median patient-churn rate was 44.6% among U.S. aesthetics operators in Q3 2026.

Customer experience in the cosmetic surgery industry

  • 60% of surveyed young U.S. plastic surgeons used social-media platforms for marketing in 2018.[10]
  • 70% of U.S. aesthetic-procedure patients considered provider before-and-after photographs important on social media in 2022.[13]
  • 70% of surveyed young U.S. plastic surgeons used a personal or practice website for marketing in 2018.[10]
  • 41% of U.S. aesthetic-procedure patients said a provider’s social-media presence positively affected their desire to become a patient in 2022.[13]
  • 45.9% of surveyed adults said before-and-after results on social media were the most influential factor when selecting a plastic surgeon in 2023.[13]

Customer retention in the cosmetic surgery industry

  • $1,628 was the median patient lifetime value among U.S. aesthetics operators in Q3 2026.[28]
  • 71.0% was the median share of patients rebooked within 90 days among 150-plus aesthetics brands in the United States in Q3 2026.[28]
  • 42.2% was the median share of patients returning from the year before among U.S. aesthetics operators in Q3 2026.[28]
  • 50.1% was the median share of revenue generated by high-value existing patients among U.S. aesthetics operators in Q3 2026.[28]
  • 44.6% was the median patient-churn rate among U.S. aesthetics operators in Q3 2026.[28]

Customer acquisition in the cosmetic surgery industry

  • 36.8% was the reported conversion rate for personal referrals in a 2026 analysis of six patient-acquisition channels used by 58 U.S. plastic-surgery clinics.[29]
  • 91% was the reported one-year increase in website traffic after a professional rebranding initiative at a plastic-surgery practice.[10]
  • 21% was the reported one-year increase in new-patient volume after a professional rebranding initiative at a plastic-surgery practice.[10]
  • 90% of patients presenting to a plastic-surgery clinic had searched online before booking a consultation, according to a study cited in 2024 research.[30]
  • 53.7% of 146,108 cosmetic-surgery patients in Japan reported the internet as their motivation for visiting a clinic between September 2018 and February 2023.[13]

Lead generation in the cosmetic surgery industry

  • 11% of surveyed young U.S. plastic surgeons posted to social media multiple times per day in 2018.[10]
  • 60% of surveyed young U.S. plastic surgeons used social-media platforms as a marketing channel in 2018.[10]
  • 70% of surveyed young U.S. plastic surgeons used a personal or practice website as a marketing channel in 2018.[10]
  • 24% of surveyed young U.S. plastic surgeons posted to social media every couple of weeks in 2018.[10]
  • 16% of surveyed young U.S. plastic surgeons posted to social media daily in 2018.[10]

09 Statistics

Marketing & Brand

Social content composition remains a measurable input to demand; 45.9% of sampled adults identified before-and-after results as the most influential social-media factor in 2023.

Marketing in the cosmetic surgery industry

  • 32.9% of sampled top Instagram posts using plastic-surgery-related hashtags were educational in 2017.[13]
  • 62.1% of Instagram posts by board-certified plastic surgeons in a sampled hashtag study were educational, compared with 38.1% from nonplastic surgeons, in 2017.[13]
  • 31% was the reported increase in plastic-surgery requests associated with social media in a cosmetic-surgery content-marketing report.[31]
  • 67.1% of sampled top Instagram posts using plastic-surgery-related hashtags were self-promotional in 2017.[13]
  • 17.8% of sampled top Instagram posts using plastic-surgery-related hashtags were from American Society for Aesthetic Plastic Surgery-eligible plastic surgeons in 2017.[13]

Digital marketing in the cosmetic surgery industry

  • 53.7% of 146,108 cosmetic-surgery patients in Japan cited the internet as a motivation for visiting a clinic between September 2018 and February 2023.[13]
  • 56% of Saudi participants reported following a cosmetic physician on social media in 2023.[13]
  • 35.1% of Saudi young adults had booked or considered booking a cosmetic consultation after viewing cosmetic-related content online in 2025.[13]
  • 49.3% of Saudi young adults reported considering a cosmetic procedure because of social-media exposure in 2025.[13]
  • 31.6% of Saudi participants reported that educational cosmetic accounts on social media influenced their consideration of plastic surgery in 2023.[13]

Branding in the cosmetic surgery industry

  • 9% of U.S. aesthetic-procedure patients preferred a provider with no social-media presence in 2022.[13]
  • 91% was the reported increase in website traffic during the first year after a professional rebranding initiative at a plastic-surgery practice.[10]
  • 55% of U.S. aesthetic-procedure patients preferred a provider with a verified social-media badge in 2022.[13]
  • 21% was the reported increase in new-patient volume during the first year after a professional rebranding initiative at a plastic-surgery practice.[10]

Social media in the cosmetic surgery industry

  • 55.4% of surveyed adults who viewed plastic-surgery content used Facebook in 2023.[13]
  • 86.4% of patients had thought about undergoing a cosmetic procedure after COVID-19, compared with 63.8% before COVID-19, in a 2019–2022 clinic study.[13]
  • 71.1% of surveyed adults who viewed plastic-surgery content used Instagram in 2023.[13]
  • 45.9% of surveyed adults identified before-and-after results as the most influential social-media factor when selecting a plastic surgeon in 2023.[13]
  • 5.5% of sampled top Instagram posts using plastic-surgery-related hashtags were created by nonphysicians in 2017.[13]

Influencer Marketing in the healthcare services sector (sector benchmark)

  • 8.57 million influencer posts about the health industry generated a 1.07% average engagement rate globally in 2023.[32]
  • 50% of healthcare and pharmaceutical marketers reported dedicated, growing creator/influencer budgets in 2026, compared with 58% globally.[33]
  • 92% of U.S.-focused health and wellness influencers included product or service promotions at least occasionally in 2026.[34]
  • 50% of U.S. physicians surveyed had changed prescribing choices based on healthcare influencer or KOL content on social media in 2024.[35]
  • 33% of U.S.-focused health and wellness influencers promoted a product, service or subscription in more than half of their posts in 2026.[34]

10 Statistics

Operations & Execution

Operational risk and complication rates remain measurable: the TOPS database recorded deep surgical-site infection of 0.2% in U.S. aesthetic-surgery patients treated from 2008–2019.

Process optimization in the cosmetic surgery industry

  • 78% of hospitals surveyed during the Baxter IV-fluid-facility closure reported risk of canceling elective surgery within the following month, including plastic-surgery procedures.[36]
  • 23.3% of microsurgical plastic-surgery cases in a U.S. dataset had operative times exceeding 10 hours during 2012–2016.[37]
  • 214,504 aesthetic-surgery patients were analyzed in the U.S. TOPS database for breast augmentation, liposuction, blepharoplasty, rhinoplasty and abdominoplasty from 2008–2019.[36]
  • 5.68% of 108,303 U.S. plastic-surgery cases in the 2012–2016 ACS NSQIP dataset were microsurgical procedures.[37]
  • Increased operative time was an independent predictor of related reoperation or surgical-site infection in 108,303 U.S. plastic-surgery cases from 2012–2016.[37]

Operational efficiency in the cosmetic surgery industry

  • 70% of U.S. aesthetic-practice owners surveyed in 2026 said running their practice was more stressful than expected.[38]
  • SBC Medical Group reported 2025 operating expenses of $59.8 million, equal to 34.44% of revenue, for its cosmetic-medical management business.[39]
  • SBC Medical Group generated $24.7 million in operating cash flow in 2025 from its cosmetic-medical management operations.[39]
  • SBC Medical Group’s operating expenses fell 30.26% year over year in 2025, from $85.7 million to $59.8 million.[39]
  • SBC Medical Group’s 2025 income from operations was $67.5 million, representing 38.87% of revenue from cosmetic-medical management services.[39]

Quality management in the cosmetic surgery industry

  • The TOPS database recorded deep surgical-site infection in 0.2% of U.S. aesthetic-surgery patients treated from 2008–2019.[36]
  • The TOPS database recorded hematoma in 0.7% of U.S. aesthetic-surgery patients treated from 2008–2019.[36]
  • 5.78% of 108,303 U.S. plastic-surgery patients experienced at least one complication in ACS NSQIP data from 2012–2016.[37]
  • The TOPS database recorded deep-vein thrombosis or pulmonary embolism in 0.1% of U.S. aesthetic-surgery patients treated from 2008–2019.[36]
  • Cosmetic-surgery medical tourism in a Colombian private practice had a 6.2% complication rate per patient and 2.2% per procedure among patients treated from 2020–2024.[36]

Supply chain in the cosmetic surgery industry

  • 78% of hospitals surveyed during a Baxter IV-fluid production disruption reported risk of canceling elective surgery within one month.[36]
  • 5% of hospitals surveyed during the Baxter disruption had already canceled elective surgery because of supply-chain effects.[36]
  • Traditional breast-implant and tissue-expander orders can contain 15–32 items, with many unused items returned to manufacturers.[13]
  • Traditional breast-implant and tissue-expander ordering commonly involves 3–4 sizes, sizers and duplicate backup items per procedure.[13]
  • Breast implants, hand and craniofacial hardware, and skin substitutes were identified as plastic-surgery supplies vulnerable to limited-manufacturer supply shortages in 2025.[36]

Outsourcing / Offshoring in the healthcare services sector (sector benchmark)

  • 43% of global healthcare providers used third-party providers for payroll services in 2024, based on a survey of 28 healthcare-provider executives.[40]
  • 29% of global healthcare providers used third-party providers for remote patient monitoring in 2024, based on a survey of 28 healthcare-provider executives.[40]
  • 18% of U.S. medical-group leaders planned to outsource or automate patient communications in contact centers in 2024, according to an MGMA poll with 262 responses.[25]
  • 46% of global healthcare providers used third-party providers for customer-experience services in 2024, based on a survey of 28 healthcare-provider executives.[40]
  • 54% of global healthcare providers used third-party providers for supply-chain services in 2024, based on a survey of 28 healthcare-provider executives.[40]

11 Statistics

Finance & Pricing

Pricing dispersion and financing availability are both visible; advertised U.S. facelift prices ranged from $7,300 to $45,200 in a 2026 state-level analysis.

Pricing strategy in the cosmetic surgery industry

  • 38% of surveyed U.S. plastic-surgery providers reported offering healthcare credit cards and 38% reported offering loans in 2023.[41]
  • 83% of surveyed U.S. plastic-surgery patients said they would pursue additional services if payment options were available in 2023.[41]
  • 72% of surveyed U.S. plastic-surgery patients said offering multiple payment options was important when choosing a provider in 2023.[41]
  • Advertised U.S. facelift prices ranged from $7,300 to $45,200 in a 2026 state-level pricing analysis.[30]
  • 16% of surveyed U.S. plastic-surgery providers reported offering in-house payment plans in 2023.[41]

Cost reduction in the cosmetic surgery industry

  • SBC Medical Group attributed part of its 2025 cost reduction to discontinuing clinic-operation support services and terminating related staff employment.[39]
  • SBC Medical Group reduced cost of revenues by $3.0 million, or 6.16%, in 2025 compared with 2024.[39]
  • A 2026 breast-implant shipping model examined annual costs created by ordering multiple sizes and duplicate backup units for cosmetic and reconstructive procedures.[13]
  • SBC Medical Group’s cost of revenues represented 26.68% of revenue in 2025, up from 24.03% in 2024.[39]
  • In the 2026 aesthetic-practice survey, 7 in 10 U.S. owners said they had made a major investment without confidence it was the right decision.[38]

Profitability in the cosmetic surgery industry

  • SBC Medical Group’s 2025 income before taxes was $82.1 million, or 47.27% of revenue.[39]
  • U.S. aesthetic practices reported typical operating-income margins of 20%–40% in a 2023 practice-management report.[42]
  • The median U.S. aesthetic-practice revenue was $3.325 million in 2020, up 0.5% from $3.310 million in 2019.[42]
  • SBC Medical Group reported a 29.37% attributable net-income margin in 2025.[39]
  • SBC Medical Group reported $127.3 million in gross profit and a 73.32% gross margin in 2025.[39]

Financial planning in the cosmetic surgery industry

  • A 2023 aesthetic-practice financial-management report identified approximately 5:1 as a debt-to-equity benchmark for practices.[42]
  • A 2023 aesthetic-practice financial-management report identified a 2:1 minimum current-ratio target for practices.[42]
  • SBC Medical Group held $240.4 million in retained earnings as of December 31, 2025.[39]
  • SBC Medical Group stated that cash and cash equivalents from operations and bank borrowings were sufficient for its working-capital needs for the following 12 months as of its 2025 annual report.[39]
  • A 2023 aesthetic-practice financial-management report identified rent of approximately 2%–6% of total practice revenue as a planning target.[42]

12 Statistics

Product & Service

Procedure volumes remain high in both categories and subtypes; non-surgical aesthetic procedures reached 20,515,686 worldwide in 2024.

Product development in the cosmetic surgery industry

  • 947,007 facial fat-grafting procedures were performed worldwide in 2024, an increase of 19.2% from 2023.[16]
  • 98,512 inverted-nipple-correction procedures were performed worldwide in 2024.[16]
  • 237,188 facial-bone-contouring procedures were performed worldwide in 2024, up 44.1% from 2023.[16]
  • 51,291 dimple-creation procedures were reported worldwide in 2024.[16]
  • 820,225 chemical-peel procedures were performed worldwide in 2024, increasing 33.3% from 2023.[16]

Product lifecycle in the cosmetic surgery industry

  • 1.2% was the five-year complication-related revision rate for cosmetic breast implants in a pooled Australian and Dutch registry cohort.[43]
  • 1.3% of cosmetic breast implants were revised for capsular contracture by six years after insertion in Australia.[44]
  • 129,854 cosmetic breast implants were included in the pooled Australian and Dutch registry cohort comparing international revision incidence.[43]
  • 5.6% of cosmetic breast implants had been revised six years after insertion in the Australian registry’s earlier report.[44]
  • 6.7% was the cumulative all-cause revision incidence eight years after cosmetic primary breast-implant insertion in Australia.[44]

After-sales in the cosmetic surgery industry

  • 51.5% of online plastic-surgery practices made at least one off-label advertisement for a cosmetic laser in a review of energy-based devices.[10]
  • 94% of respondents in a multinational aesthetic-procedure survey were offered at least one follow-up service after treatment.[1]
  • 8.2 out of 10 was the mean treatment-outcome satisfaction score reported across respondents in a multinational aesthetic-procedure survey.[1]
  • 57 patients were included in a study of smartphone-based postoperative follow-up after cosmetic surgery.[13]
  • 15 of 20 patients, or 75%, received combined breast and abdominal procedure recommendations from ChatGPT-4 in an aesthetic-surgery study.[13]

Value proposition in the cosmetic surgery industry

  • 2,087,189 liposuction procedures were performed worldwide in 2024, making liposuction the second-leading surgical procedure.[16]
  • 7,497,709 face-and-head surgical procedures were performed worldwide in 2024, up 4.3% from 2023.[16]
  • 20,515,686 non-surgical aesthetic procedures were performed worldwide in 2024 by plastic surgeons.[16]
  • 37,931,364 total surgical and non-surgical aesthetic procedures were reported worldwide in 2024.[16]
  • 1,658,615 breast-augmentation procedures were performed worldwide in 2024.[16]

13 Statistics

Sustainability & Ethics

Emissions and waste show quantifiable variation across interventions; 22.7 kgCO2e was the average carbon footprint per procedure among plastic-surgery sustainability studies reporting emissions.

Sustainability in the cosmetic surgery industry

  • 2,179 kg of CO2 could be saved annually by retrofitting aesthetic and surgical clinics with LED lighting, according to a review of clinic interventions.[13]
  • 10.9 kg of CO2 emissions per procedure could be reduced through leaner use of 10 key disposable surgical items in a plastic-surgery department study.[13]
  • 39.6 tonnes of waste per month were redirected to recycling on average in plastic-surgery sustainability initiatives reviewed internationally.[13]
  • 22.7 kgCO2e was the average carbon footprint per procedure among plastic-surgery sustainability studies reporting emissions.[13]
  • 16,023 kg of CO2 could be avoided annually through solar-panel installation in the aesthetic and surgical clinic model reviewed.[13]

Ethics in the cosmetic surgery industry

  • 54.3% of plastic-surgery litigation cases ended in outcomes favorable to surgeons, based on the pooled estimate in a facial-plastic-surgery systematic review.[10]
  • 60.9% of malpractice verdicts favored physicians in a review of lawsuits against nonplastic surgeons performing cosmetic surgery.[36]
  • 48.7% of complications in litigated aesthetic body-surgery cases were infections, making infection the most frequent complication in the systematic review.[10]
  • More than 50% of aesthetic body-surgery litigation cases included inadequate informed consent as a leading allegation.[10]
  • 26.8% of complications in litigated aesthetic body-surgery cases were fat embolisms in the systematic review.[10]

Carbon footprint in the cosmetic surgery industry

  • 160.95 kgCO2e was the largest reported global-warming contribution from disposable supplies in a facial-plastic-surgery operating-room assessment.[13]
  • 28.5 kgCO2e was the lower end of the per-operation range in a 2023 systematic review of surgical carbon footprints that included plastic-surgery evidence.[10]
  • More than 400 kgCO2e was reported for some complex single-stage surgical operations in a 2026 systematic review that included plastic surgery.[10]
  • 505.1 kgCO2e was the upper end of the per-operation range in a 2023 systematic review of surgical carbon footprints that included plastic-surgery evidence.[10]
  • Approximately 1,000 kgCO2e was reported for some complete multistage surgical patient pathways in a 2026 systematic review including plastic surgery.[10]

15 Statistics

Globalization & Expansion

Global procedure counts remain the core demand signal; ISAPS recorded 17,415,678 surgical procedures in 2024.

Globalization in the cosmetic surgery industry

  • 1,083,631 rhinoplasty procedures were performed worldwide in 2024.[16]
  • 37,951,364 aesthetic procedures were performed worldwide in 2024, comprising 17,415,678 surgical and 20,535,686 nonsurgical procedures.[16]
  • 947,007 facial fat-grafting procedures were performed worldwide in 2024.[16]
  • 1,658,615 breast-augmentation procedures were reported worldwide in 2024.[16]
  • 7,887,955 botulinum-toxin treatments were performed worldwide in 2024.[16]

Cultural adaptation in the cosmetic surgery industry

  • 54.5% of surveyed Saudi Arabian respondents had no preference regarding the sex of their cosmetic surgeon.[36]
  • 55.9% of South Korean respondents in a five-region East Asian survey reported surgical cosmetic experience exceeding their nonsurgical cosmetic experience.[10]
  • 32.1% of surveyed Saudi Arabian respondents reported that culture had a moderate influence on their cosmetic-surgery decisions.[36]
  • 41% of surveyed Saudi Arabian respondents cited improving facial appearance as their most common reason for considering cosmetic intervention.[36]
  • 27.5% of surveyed Saudi Arabian respondents cited enhancing a specific feature, such as the nose, jawline or skin texture, as a reason for considering cosmetic intervention.[36]

Stakeholder management in the cosmetic surgery industry

  • Nearly 40 global experts, including healthcare professionals and influencers, helped develop Galderma’s NEXT aesthetics trend report in 2024.[18]
  • More than 225,000 healthcare professionals were reached through Galderma education, training and medical-awareness activities in 2024.[18]

Distribution channels in the cosmetic surgery industry

  • Galderma’s Aesthetic Injector Network supported international medical-aesthetics education and training events in 2024.[18]
  • Galderma’s injectable-aesthetics portfolio was present in approximately 90 countries in 2024.[18]
  • Galderma presented its aesthetics portfolio at major congresses including AMWC, AAD, EADV, Vegas Cosmetic Surgery and IMCAS in 2024.[18]

Key questions about the Cosmetic Surgery Industry

What is the global cosmetic surgery and procedure market size?
The global cosmetic surgery and procedure market was valued at $72.8 billion in 2025.
How fast is the cosmetic surgery and procedure market expected to grow?
Grand View Research estimates the market will reach $80.0 billion in 2026, with a projected 10.5% CAGR from 2026 to 2033.
Which companies lead the cosmetic surgery industry?
AbbVie leads Gitnux's 2026 cosmetic surgery ranking with an Overall score of 9.6, with Allergan Aesthetics generating $4.86 billion in global 2025 aesthetics revenue. Galderma is the runner-up at 9.3, backed by $5.207 billion 2025 net sales and 11.5% injectable-aesthetics growth.
What technology shifts are showing up in cosmetic medicine?
IMCAS 2024 respondents reported 53.2% currently using AI technologies in cosmetic medicine, with 48.9% expressing reservations about AI data privacy and security.
How is the industry structured across providers and settings?
The industry is fragmented across independent surgeons, specialist clinics, hospitals, medical-spa groups, and device and injectable manufacturers.
What consumer demand signals are shaping procedure-versus-nonsurgical competition?
ISAPS recorded 17.4 million surgical procedures versus 20.5 million non-surgical procedures in 2024, and GLP-1 users show split intent: 20% already had plastic surgery and 41% were considering a non-surgical procedure.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Lars Eriksen. (2026, February 13). Cosmetic Surgery Industry Statistics. Gitnux. https://gitnux.org/cosmetic-surgery-industry-statistics
MLA
Lars Eriksen. "Cosmetic Surgery Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cosmetic-surgery-industry-statistics.
Chicago
Lars Eriksen. 2026. "Cosmetic Surgery Industry Statistics." Gitnux. https://gitnux.org/cosmetic-surgery-industry-statistics.